3D011
/ 3DMed
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 16, 2024
3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: 3D Medicines (Beijing) Co., Ltd. | N=93 ➔ 0 | Trial completion date: Dec 2023 ➔ Sep 2023 | Recruiting ➔ Withdrawn | Trial primary completion date: Dec 2023 ➔ Sep 2023
Enrollment change • Metastases • Monotherapy • Trial completion date • Trial primary completion date • Trial withdrawal • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor
March 08, 2022
3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=93 | Recruiting | Sponsor: 3D Medicines (Beijing) Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
1 to 2
Of
2
Go to page
1